Skip to main content
Caplight Logo









Exactics

Exactics

Private
Chicago, IllinoisHealthcare & Life Scienceshttps://www.exacticsbiotech.com/

Last Round

Seed Round

Jun 25, 2026

Total Funding Raised

$3.46M

Momentum

Top 25%

of companies Caplight tracks

Company Overview

Exactics is a biotechnology company that develops affordable, accurate, and accessible at-home rapid diagnostic tools for infectious diseases using its proprietary Proteus+ platform.

Sector

Healthcare & Life Sciences

Verticals

Biotechnology, Medical Devices, D2C Brands

Business Model

B2C

Customer Profile

Hardware Sales, Hardware + Subscription

AI Layer

Non-AI

Keywords

at-home diagnosticrapid diagnostic testpoint-of-need testinglateral flow assayLyme disease testhome health kitveterinary diagnosticsinfectious disease testingdiagnostic platformdirect-to-consumerD2Cmedical devicebiotech startuphealth tech

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Exactics Comparables

Compare Exactics with similar companies based on industry and business-model similarity.

Exactics comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
LymeAlert
93%
En Carta Diagnostics
74%
MedZu Inc.
69%

Exactics Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
Seed RoundJun 25, 2026
GrantMar 10, 2026
SeedNov 21, 2025
SeedJul 6, 2025
GrantMay 29, 2025
Grant
Apr 18, 2025

Key People

Founding team and executive leadership

Maxwell Almeida

Co-Founder & Chief Technology Officer

Founding Team

Zachary Sarmoen

Co-Founder & Chief Financial Officer

Founding Team

Julian Kage

Chairman and Chief Executive Officer

Executive Team

Madeline Murray

Chief Operating Officer

Executive Team

Market signals

Structured signals derived from secondary market and firmographic data.

  • Jul 24, 2026

    Monthly visitors grew 630% MoM.

  • Jun 25, 2026

    $855K raised in Seed Round.

Exactics Filings

Explore SEC and related filing metadata, where available.

Exactics filings preview — column headings only; records require access
TypeDateAmount OfferedAmount SoldFilingPagesDownload

Filing documents are not displayed on this public page. Request access to learn about available coverage.

Request access

Frequently Asked Questions

Common questions about Exactics's valuation, stock price, and market status.

Is Exactics a public or private company?

Exactics is a private company.

What is the current stock price of Exactics?

Exactics is a private company with no public stock price. No recent secondary market data is available.

How much is Exactics worth (valuation)?

Valuation information for Exactics is not publicly available.

Can I buy Exactics stock?

Exactics shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.

When was Exactics's last funding round?

Exactics's most recent funding round was Seed Round on June 25, 2026.

Who are the main investors in Exactics?

Key investors in Exactics include Rustandy Center for Social Sector Innovation, Albert Lepage Center for Entrepreneurship and Innovation.

Will Exactics IPO soon?

No public IPO plans have been announced for Exactics.

How can I track Exactics secondary market activity?

Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor Exactics's secondary market activity and sign up for updates.

Firmographic Details

HeadquartersChicago, Illinois
Employee Range8
Year Founded2021
Last FundingJun 25, 2026

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.

See something wrong or outdated?